Nicotine Reinforcement and Aversion in Young Adult Light Smokers
Sponsor: National Institute on Drug Abuse (NIDA)
A EARLY_PHASE1 clinical study on Nicotine Addiction, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 16 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2023 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Completed EARLY_PHASE1
-
Sep 2021 — Dec 2022 [monthly]
Completed EARLY_PHASE1
Phase: NA → EARLY_PHASE1
▶ Show 11 earlier versions
-
Mar 2021 — Sep 2021 [monthly]
Completed NA
Status: Suspended → Completed
-
Jan 2021 — Mar 2021 [monthly]
Suspended NA
-
Sep 2020 — Jan 2021 [monthly]
Suspended NA
-
May 2020 — Sep 2020 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Apr 2020 — May 2020 [monthly]
Recruiting NA
-
Nov 2019 — Apr 2020 [monthly]
Recruiting NA
-
Oct 2018 — Nov 2019 [monthly]
Recruiting NA
-
Jun 2018 — Oct 2018 [monthly]
Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Drug Abuse (NIDA)
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .